Protagenic Therapeutics, Inc. Files Form 8-K Current Report with SEC – Company Details, Addresses, and Trading Symbols (Feb. 3, 2026)
Protagenic Therapeutics, Inc. Files Form 8-K: Key Details fo...
Sign in to continue:
Protagenic Therapeutics, Inc. Files Form 8-K: Key Details fo...
Slam Corp. - Investor Update: Changes in Control and Shell C...
Knightscope Acquires Event Risk: Strategic Move Toward Auton...
Tonix Pharmaceuticals Announces Uplisting to Nasdaq Global S...
Versus Systems Extends Partnership with Texas Rangers, Unvei...
Haemonetics Corporation Repays Convertible Senior Notes Due ...
Hycroft Mining 2025 Results & 2026 Outlook: Detailed Investo...
Wabtec Unveils Ambitious 2025-2029 Strategy, Projects Strong...
Chiron Real Estate Inc. Files Form 8-K: Major Debt Facility ...
THOR Industries Reports Fiscal Q2 2026 Earnings: Detailed An...